TAKEDA PHARMA A/S — Credit Rating and Financial Key Figures
CVR number: 16406899
Delta Park 45, 2665 Vallensbæk Strand
info@takeda.dk
tel: 46771111
Income statement (mDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | 1 570.00 | 1 939.00 | 910.00 | 1 061.21 | 1 118.71 |
| Other operating income | 272.51 | ||||
| Purchases during the financial year | - 858.95 | - 871.02 | |||
| External services | -81.68 | -82.49 | |||
| Gross profit | 1 570.00 | 1 939.00 | 910.00 | 120.58 | 437.70 |
| Employee benefit expenses | -93.15 | -91.61 | |||
| Total depreciation | -6.59 | -8.51 | |||
| EBIT | 1 570.00 | 1 939.00 | 910.00 | 20.84 | 337.59 |
| Other financial income | 0.54 | 1.60 | |||
| Other financial expenses | -0.53 | -3.47 | |||
| Pre-tax profit | 20.85 | 335.73 | |||
| Income taxes | -7.28 | -74.50 | |||
| Net earnings | 13.57 | 261.22 |
Assets (mDKK)
2022 | 2023 | |
|---|---|---|
| Intangible rights | 1.44 | |
| Intangible assets total | 1.44 | |
| Land and waters | 13.28 | 10.23 |
| Buildings | 24.27 | |
| Machinery and equipment | 5.32 | 5.57 |
| Advance payments and construction in progress | 0.63 | |
| Tangible assets total | 42.87 | 16.43 |
| Holdings in group member companies | 29.20 | 16.99 |
| Investments total | 29.20 | 16.99 |
| Non-current other receivables | 2.00 | 1.94 |
| Long term receivables total | 2.00 | 1.94 |
| Raw materials and consumables | 6.45 | 3.10 |
| Finished products/goods | 132.54 | 154.84 |
| Inventories total | 138.99 | 157.94 |
| Current trade debtors | 91.84 | 114.84 |
| Current amounts owed by group member comp. | 117.80 | 262.85 |
| Current other receivables | 13.12 | 6.93 |
| Current deferred tax assets | 48.48 | 4.46 |
| Short term receivables total | 271.24 | 389.07 |
| Cash and bank deposits | 0.00 | 0.00 |
| Cash and cash equivalents | 0.00 | 0.00 |
| Balance sheet total (assets) | 485.75 | 582.37 |
Equity and liabilities (mDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 2 707.00 | 1 046.00 | 81.00 | 10.10 | 10.10 |
| Other reserves | 0.14 | -0.03 | |||
| Retained earnings | 71.08 | 84.66 | |||
| Profit of the financial year | 13.57 | 261.22 | |||
| Shareholders equity total | 2 707.00 | 1 046.00 | 81.00 | 94.89 | 355.95 |
| Provisions | 2.93 | ||||
| Non-current leasing loans | 11.75 | 9.28 | |||
| Non-current deferred tax liabilities | 0.91 | 1.43 | |||
| Non-current liabilities total | 12.66 | 10.70 | |||
| Current trade creditors | 25.36 | 24.15 | |||
| Current owed to group member | 304.79 | 93.21 | |||
| Short-term deferred tax liabilities | 52.55 | ||||
| Other non-interest bearing current liabilities | 45.13 | 45.81 | |||
| Current liabilities total | 375.27 | 215.72 | |||
| Balance sheet total (liabilities) | 2 707.00 | 1 046.00 | 81.00 | 485.75 | 582.37 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.